AssetMark Inc
DXCM icon

AssetMark Inc’s DexCom DXCM Stock Holding History

AssetMark Inc’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.7M Buy
173,368
+12,000
+7% +$799K 0.02% 526
2026
Q1 		$10.1M Buy
161,368
+17,750
+12% +$1.24M 0.02% 501
2025
Q4 		$9.53M Buy
143,618
+142,256
+10,445% +$9.2M 0.02% 509
2025
Q3 		$91.6K Sell
1,362
-123
-8% -$9.73K ﹤0.01% 1462
2025
Q2 		$130K Buy
1,485
+546
+58% +$42.8K ﹤0.01% 1316
2025
Q1 		$64.1K Sell
939
-384
-29% -$31.3K ﹤0.01% 1378
2024
Q4 		$103K Sell
1,323
-38,408
-97% -$2.84M ﹤0.01% 1246
2024
Q3 		$2.66M Sell
39,731
-1,283
-3% -$105K 0.01% 590
2024
Q2 		$4.65M Buy
41,014
+1,442
+4% +$182K 0.01% 446
2024
Q1 		$5.49M Buy
39,572
+881
+2% +$111K 0.02% 399
2023
Q4 		$4.8M Sell
38,691
-7,449
-16% -$761K 0.02% 378
2023
Q3 		$4.3M Buy
46,140
+3,132
+7% +$353K 0.02% 369
2023
Q2 		$5.53M Buy
43,008
+3,740
+10% +$452K 0.02% 322
2023
Q1 		$4.56M Sell
39,268
-2,733
-7% -$306K 0.02% 329
2022
Q4 		$4.76M Buy
42,001
+2,350
+6% +$258K 0.02% 309
2022
Q3 		$3.19M Sell
39,651
-1,115
-3% -$94.4K 0.01% 318
2022
Q2 		$3.04M Buy
40,766
+4,534
+13% +$414K 0.01% 300
2022
Q1 		$4.63M Buy
36,232
+18,768
+107% +$2.05M 0.02% 267
2021
Q4 		$2.34M Buy
17,464
+15,948
+1,052% +$2.29M 0.01% 309
2021
Q3 		$207K Buy
1,516
+808
+114% +$102K ﹤0.01% 567
2021
Q2 		$76K Sell
708
-1,204
-63% -$116K ﹤0.01% 684
2021
Q1 		$172K Sell
1,912
-184
-9% -$17.3K ﹤0.01% 574
2020
Q4 		$194K Sell
2,096
-536
-20% -$47.9K ﹤0.01% 548
2020
Q3 		$271K Sell
2,632
-116
-4% -$12.1K ﹤0.01% 483
2020
Q2 		$279K Buy
2,748
+2,232
+433% +$200K ﹤0.01% 457
2020
Q1 		$35K Sell
516
-52
-9% -$3.24K ﹤0.01% 758
2019
Q4 		$31K Sell
568
-624
-52% -$29.6K ﹤0.01% 844
2019
Q3 		$44K Buy
1,192
+52
+5% +$2.02K ﹤0.01% 746
2019
Q2 		$43K Buy
1,140
+624
+121% +$19.6K ﹤0.01% 734
2019
Q1 		$15K Sell
516
-216
-30% -$7.59K ﹤0.01% 928
2018
Q4 		$22K Sell
732
-372
-34% -$11.8K ﹤0.01% 863
2018
Q3 		$39K Sell
1,104
-128
-10% -$3.97K ﹤0.01% 794
2018
Q2 		$29K Sell
1,232
-532
-30% -$11.3K ﹤0.01% 837
2018
Q1 		$33K Sell
1,764
-40
-2% -$591 ﹤0.01% 834
2017
Q4 		$26K Sell
1,804
-800
-31% -$10.4K ﹤0.01% 954
2017
Q3 		$32K Buy
2,604
+788
+43% +$13.9K ﹤0.01% 816
2017
Q2 		$33K Buy
1,816
+1,568
+632% +$29K ﹤0.01% 780
2017
Q1 		$5K Sell
248
-108
-30% -$2.11K ﹤0.01% 1032
2016
Q4 		$5K Buy
356
+212
+147% +$3.76K ﹤0.01% 1036
2016
Q3 		$3K Buy
144
+140
+3,500% +$3.12K ﹤0.01% 1089
2016
Q2 		$0 Hold
4
– – ﹤0.01% 1191
2016
Q1 		$0 Sell
4
-112
-97% -$1.87K ﹤0.01% 1228
2015
Q4 		$2K Buy
116
+104
+867% +$2.16K ﹤0.01% 1085
2015
Q3 		$0 Buy
+12
New +$268 ﹤0.01% 755

Other funds holding DXCM

SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
FFM
Fisher Funds Management Auckland, New Zealand $3.52B AUM 17.59% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
FMI
Factory Mutual Insurance Waltham, Massachusetts $10.6B AUM 34.1% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

AssetMark Inc's DXCM Position: Q2 2026 in Review

AssetMark Inc increased its DexCom (DXCM) stake by 7.4% in Q2 2026, buying an estimated $799K and bringing the position to 173,368 shares worth $11.7M. The position accounts for 0.02% of the portfolio, ranked #526.

AssetMark Inc first reported a position in DXCM in Q3 2015 and has held it in 44 quarters since. 353 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • AssetMark Inc held 173,368 shares of DexCom worth $11.7M as of Q2 2026.
  • AssetMark Inc bought 12,000 DexCom shares in Q2 2026, an estimated $799K.
  • DexCom made up 0.02% of AssetMark Inc's portfolio in Q2 2026, its #526 holding.
  • AssetMark Inc first reported a position in DexCom in Q3 2015 and has held it in 44 quarters since.
  • 353 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on AssetMark Inc's 13F filing for Q2 2026, filed 30 Jul 2026.